GGrantIndex
← Leaderboards

Elizabeth Mormino

Stanford University

$14,132,355
Attributed
$68,111,939
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $32.3M · FY200825
$50M$37.5M$25M$12.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$68,111,939 · 9

By mechanism

U01$60,357,563 · 1
R01$4,739,441 · 1
P30$1,750,084 · 3
K01$641,628 · 1
R21$431,750 · 1
F32$101,140 · 1

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposPositron-Emission TomographyMagnetic Resonance ImagingS DiseaseAmyloidAmyloid Beta-ProteinPatternTau ProteinsDementiaBiological MarkersIn VivoBrainImageTemporal LobePre-ClinicalImpaired CognitionPathologyNeurodegenerative DisordersThickParticipantEnrollmentFunctional Magnetic Resonance ImagingNeuroimagingNerve Degeneration

Grant awards (23)

Hippocampal-dependent memory decline in aging and early Alzheimer's disease$1,106,811
R01 · FY2025 · AG · contact PI
Imaging Core$165,022
P30 · FY2025 · AG · contact PI
ADRC Consortium for Clarity in ADRD Research Through Imaging$29,557,545
U01 · FY2024 · AG
Hippocampal-dependent memory decline in aging and early Alzheimer's disease$1,206,277
R01 · FY2024 · AG · contact PI
Imaging Core$329,798
P30 · FY2024 · AG · contact PI
ADRC Consortium for Clarity in ADRD Research Through Imaging$30,800,018
U01 · FY2023 · AG
Hippocampal-dependent memory decline in aging and early Alzheimer's disease$1,206,277
R01 · FY2023 · AG · contact PI
Imaging Core$313,872
P30 · FY2023 · AG · contact PI
Hippocampal-dependent memory decline in aging and early Alzheimer's disease$1,220,076
R01 · FY2022 · AG · contact PI
Imaging Core$432,866
P30 · FY2022 · AG · contact PI
Imaging Core$508,526
P30 · FY2021 · AG · contact PI
Influence of genetic risk factors on biomarkers and cognitive decline in preclinical AD$127,467
K01 · FY2020 · AG · contact PI
The impact of early medial temporal lobe Tau in human cognitive aging$196,250
R21 · FY2019 · AG · contact PI
Influence of genetic risk factors on biomarkers and cognitive decline in preclinical AD$127,467
K01 · FY2019 · AG · contact PI
The impact of early medial temporal lobe Tau in human cognitive aging$235,500
R21 · FY2018 · AG · contact PI
Influence of genetic risk factors on biomarkers and cognitive decline in preclinical AD$127,467
K01 · FY2018 · AG · contact PI
Influence of genetic risk factors on biomarkers and cognitive decline in preclinical AD$127,467
K01 · FY2017 · AG · contact PI
Influence of genetic risk factors on biomarkers and cognitive decline in preclinical AD$131,760
K01 · FY2016 · AG · contact PI
Deficits in top-down processes during episodic memory in aging and preclinical AD$50,711
F32 · FY2014 · AG · contact PI
Deficits in top-down processes during episodic memory in aging and preclinical AD$50,429
F32 · FY2012 · AG · contact PI
Relating amyloid pathology to cognition and brain changes in normal elderly indiv$26,907
F31 · FY2010 · AG · contact PI
Relating amyloid pathology to cognition and brain changes in normal elderly indiv$32,130
F31 · FY2009 · AG · contact PI
Relating amyloid pathology to cognition and brain changes in normal elderly indiv$31,296
F31 · FY2008 · AG · contact PI